The CD40/CD40 ligand system is involved in the pathogenesis of pemphigus

Clinical Immunology

Volumn 124, Issue 1, 2007, Pages 22-25

  Caproni, Marzia ^a   Antiga, Emiliano ^a   Torchia, Daniele ^a   Volpi, Walter ^a   del Bianco, Elena ^a   Cappetti, Alessio ^a   Feliciani, Claudio ^b   Fabbri, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

CD40; CD40 ligand; Enzyme linked immunosorbent assay; Immunohistochemistry; Pemphigus; Reversal transcriptase polymerase chain reaction

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; MESSENGER RNA;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SKIN BIOPSY; UPREGULATION;

ACANTHOLYSIS; ADULT; AGED; ANTIGENS, CD40; AUTOANTIBODIES; BIOPSY; CD40 LIGAND; DESMOGLEIN 1; DESMOGLEIN 3; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEMPHIGUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN;

EID: 34250669515     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.04.007     Document Type: Article

References (13)

1. Hertl M., Eming R., and Veldman C. T cell control in autoimmune bullous skin disorders. J. Clin. Invest. 116 (2006) 1159-1166
2. Schonbeck U., and Libby P. The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 58 (2001) 4-43
3. Caproni M., Torchia D., Schincaglia E., Volpi W., Frezzolini A., Schena D., Marzano A., Quaglino P., De Simone C., Parodi A., Barletta E., and Fabbri P. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br. J. Dermatol. 155 (2006) 722-728
4. Caproni M., Torchia D., Cardinali C., Volpi W., Del Bianco E., D'Agata A., and Fabbri P. Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br. J. Dermatol. 151 (2004) 784-791
5. Aoki-Ota M., Kinoshita M., Ota T., Tsunoda K., Iwasaki T., Tanaka S., Koyasu S., Nishikawa T., and Amagai M. Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model. J. Invest. Dermatol. 126 (2006) 105-113
6. Del Prete G., De Carli M., Almerigogna F., Daniel K.C., D'Elios M.M., Zancuoghi G., Vinante F., Pizzolo G., and Romagnani S. Preferential expression of CD30 by human CD4 + T cells producing Th2-type cytokines. FASEB J. 9 (1995) 81-86
7. McGregor C.M., Schoenberger S.P., and Green E.A. CD154 is a negative regulator of autoaggressive CD8+T cells in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9345-9350
8. Liu Z., Li N., and Diaz L.A. Inhibition of pemphigus vulgaris by targeting of the CD40-CD154 co-stimulatory pathway: a step toward antigen-specific therapy?. J. Invest. Dermatol. 126 (2006) 11-13
9. Feliciani C., Toto P., Amerio P., Pour S.M., Coscione G., Shivji G., Wang B., and Sauder D.N. In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis. J. Invest. Dermatol. 114 (2000) 71-77
10. Caproni M., Giomi B., Cardinali C., Salvatore E., Pestelli E., D'Agata A., Bianchi B., Toto P., Feliciani C., and Fabbri P. Further support for a role for Th2-like cytokines in blister formation of pemphigus. Clin. Immunol. 98 (2001) 264-271
11. Siebra M.X., Santos M.A., Almeida T.L., Leite A.C., Cunha F.Q., and Rocha F.A. Evidence for the participation of nitric oxide in pemphigus. Braz. J. Med. Biol. Res. 39 (2006) 671-675
12. Kato K., Santana-Sahagun E., Rassenti L.Z., Weisman M.H., Tamura N., Kobayashi S., Hashimoto H., and Kipps T.J. The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J. Clin. Invest. 104 (1999) 947-955
13. Goules A., Tzioufas A.G., Manousakis M.N., Kirou K.A., Crow M.K., and Routsias J.G. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J. Autoimmun. 26 (2006) 165-171